ATC level 4
R03DXAsthma and COPD medicines, subgroup R03D, subgroup R03DX
- Molecules
- 7
- Subgroups
- 7
ATC R03DX (Asthma and COPD medicines, subgroup R03D, subgroup R03DX) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 7 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under R03DX.
- BenralizumabOrphanInterleukin-5 Receptor alpha-directed Cytolytic Antibody2 presentations2 brandsR03DX10
- DepemokimabBiologic1 presentation2 brandsR03DX12
- MepolizumabOrphanInterleukin-5 Antagonist3 presentations2 brandsL04AC06
- OmalizumabBiologicAnti-IgE7 presentations5 brandsR03DX05
- ReslizumabBiologicInterleukin-5 Antagonist1 presentation2 brandsR03DX08
- RoflumilastPhosphodiesterase 4 Inhibitor8 presentations3 brandsR03DX07
- TezepelumabBiologicThymic Stromal Lymphopoietin Blocker1 presentation2 brandsR03DX11
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.